{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:17:01Z","timestamp":1777285021019,"version":"3.51.4"},"reference-count":67,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (NSFC)","doi-asserted-by":"publisher","award":["82003846"],"award-info":[{"award-number":["82003846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>L-3-[18F]-fluoro-\u03b1-methyl tyrosine ([18F]FAMT) is an amino acid positron emission tomography (PET) tracer with high specificity for malignant tumors through its selective transport via L-type amino acid transporter (LAT) 1. Although extensively studied for its diagnostic performance, a comprehensive review of its molecular and clinical characteristics remains lacking. A systematic literature review (1997\u20132025) was conducted using PubMed and Web of Science, with keywords including \u201cL-3-[18F]-fluoro-\u03b1-methyl tyrosine\u201d, \u201c[18F]FAMT\u201d, \u201camino acid PET\u201d, and \u201ctumor imaging\u201d. The review covered aspects of synthesis, structural properties, pharmacokinetics, and clinical applications. Notably, while research on [18F]FAMT has declined significantly in recent years, [18F]FAMT PET demonstrates superior specificity to [18F]FDG PET in distinguishing malignancies from inflammatory lesions and offers distinct advantages in lung, esophageal, and oral cancers, though with slightly lower sensitivity. Its key features include tumor-specific uptake patterns, rapid blood clearance, and a significant correlation between its uptake levels and both LAT1 expression and tumor proliferation. In conclusion, [18F]FAMT is a promising PET tracer with notable advantages in tumor imaging, particularly due to its LAT1 selectivity and favorable pharmacokinetics. Despite challenges in production, these characteristics underscore its clinical value in cancers requiring precise imaging. Future research should focus on optimizing synthesis, expanding clinical validation, and exploring theranostic applications.<\/jats:p>","DOI":"10.3390\/ijms26125848","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T09:36:00Z","timestamp":1750239360000},"page":"5848","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["L-3-[18F]-Fluoro-\u03b1-Methyl Tyrosine as a PET Tracer for Tumor Diagnosis: A Systematic Review from Mechanisms to Clinical Applications"],"prefix":"10.3390","volume":"26","author":[{"given":"Mei","family":"Bao","sequence":"first","affiliation":[{"name":"School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gu","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Tong","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Chu","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinmao","family":"Ye","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6657-5059","authenticated-orcid":false,"given":"Kazuko","family":"Kaneda-Nakashima","sequence":"additional","affiliation":[{"name":"Division of Radiation Science, Institute for Radiation Sciences, Osaka University, 2-4 Yamadaoka, Suita 565-0871, Osaka, Japan"},{"name":"Core for Medicine and Science Collaborative Research and Education, Forefront Research Center, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5782-8226","authenticated-orcid":false,"given":"Wenbin","family":"Hou","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiliang","family":"Li","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6633-6410","authenticated-orcid":false,"given":"Ling","family":"Wei","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.2967\/jnumed.107.045930","article-title":"Tumor Cell Metabolism Imaging","volume":"49","author":"Plathow","year":"2008","journal-title":"J. Nucl. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.2967\/jnumed.123.266314","article-title":"Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview","volume":"65","author":"Zhang","year":"2024","journal-title":"J. Nucl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Cri\u0219an, G., Moldovean-Cioroianu, N.S., Timaru, D.G., Andrie\u0219, G., C\u0103inap, C., and Chi\u0219, V. (2022). Radiopharmaceuticals for PET and SPECT Im-aging: A Literature Review over the Last Decade. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095023"},{"key":"ref_4","first-page":"930","article-title":"GLUT1 expression in tissue and (18)F-FDG uptake","volume":"45","author":"Avril","year":"2004","journal-title":"J. Nucl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1148\/radiology.220.1.r01jl1654","article-title":"Detection of Malignant Tumors: Whole-Body PET with Fluorine 18 \u03b1-Methyl Tyrosine versus FDG\u2014Preliminary Study","volume":"220","author":"Inoue","year":"2001","journal-title":"Radiology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13139-011-0075-y","article-title":"Current Molecular Imaging Positron Emitting Radiotracers in Oncology","volume":"45","author":"Zhu","year":"2011","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2967\/jnumed.112.113100","article-title":"Radiolabeled Amino Acids for Oncologic Imaging","volume":"54","author":"Huang","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s002590050265","article-title":"Estimation of internal absorbed dose of l-[methyl-11C]methionine using whole-body positron emission tomography","volume":"25","author":"Deloar","year":"1998","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Urso, L., Bonatto, E., Nieri, A., Castello, A., Maffione, A.M., Marzola, M.C., Cittanti, C., Bartolomei, M., Panareo, S., and Mansi, L. (2023). The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review. Cancers, 15.","DOI":"10.3390\/cancers15072184"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s13244-010-0062-3","article-title":"Causes and imaging features of false positives and false negatives on 18F-PET\/CT in oncologic imaging","volume":"2","author":"Long","year":"2011","journal-title":"Insights Into Imaging"},{"key":"ref_12","first-page":"432","article-title":"Radiolabeled amino acids: Basic aspects and clinical applications in oncology","volume":"42","author":"Jager","year":"2001","journal-title":"J. Nucl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00006231-199702000-00013","article-title":"Synthesis of isomers of 18F-labelled amino acid radiopharmaceutical: Position 2- and 3-L-18F-alpha-methyltyrosine using a separation and purification system","volume":"18","author":"Tomiyoshi","year":"1997","journal-title":"Nucl. Med. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2967\/jnumed.112.103069","article-title":"Transport of 3-Fluoro-l-\u03b1-Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET","volume":"53","author":"Wiriyasermkul","year":"2012","journal-title":"J. Nucl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/cas.12878","article-title":"Specific transport of 3-fluoro-l-alpha-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging","volume":"107","author":"Wei","year":"2016","journal-title":"Cancer Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107964","DOI":"10.1016\/j.pharmthera.2021.107964","article-title":"Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics","volume":"230","author":"Kanai","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"20787","DOI":"10.1074\/jbc.M000634200","article-title":"Transport Properties of a System y+L Neutral and Basic Amino Acid Transporter","volume":"275","author":"Kanai","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/812973","article-title":"18F-Labelled Intermediates for Radiosynthesis by Modular Build-Up Reactions: Newer Developments","volume":"2014","author":"Ermert","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1874471011003020109","article-title":"Nucleophilic 18F-Fluorination of Complex Molecules in Activated Carbocyclic Aromatic Position","volume":"3","author":"Ermert","year":"2010","journal-title":"Curr. Radiopharm."},{"key":"ref_21","first-page":"778","article-title":"(C-11) methionine pancreatic scanning with positron emission computed-tomography","volume":"20","author":"Syrota","year":"1979","journal-title":"J. Nucl. Med."},{"key":"ref_22","first-page":"205","article-title":"Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging","volume":"40","author":"Wester","year":"1999","journal-title":"J. Nucl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.bjc.6604235","article-title":"Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I\u2013III nonsmall cell lung cancer","volume":"98","author":"Kaira","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12149-013-0687-7","article-title":"Biological evaluation of 3-[18F]fluoro-\u03b1-methyl-d-tyrosine (d-[18F]FAMT) as a novel amino acid tracer for positron emission tomography","volume":"27","author":"Ohshima","year":"2013","journal-title":"Ann. Nucl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jfluchem.2015.07.015","article-title":"Stereoselective radiosynthesis of l- and d-3-[18F]fluoro-\u03b1-methyltyrosine","volume":"178","author":"Humpert","year":"2015","journal-title":"J. Fluor. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","article-title":"Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)","volume":"273","author":"Kanai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_27","first-page":"1","article-title":"The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41594-019-0237-7","article-title":"Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc","volume":"26","author":"Lee","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0005-2736(01)00384-4","article-title":"Human L-type amino acid transporter 1 (LAT1): Characterization of function and expression in tumor cell lines","volume":"1514","author":"Yanagida","year":"2001","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ijc.21866","article-title":"L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors","volume":"119","author":"Nawashiro","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.nucmedbio.2010.06.004","article-title":"Comparison of l-type amino acid transporter 1 expression and l-[3-18F]-\u03b1-methyl tyrosine uptake in outcome of non-small cell lung cancer","volume":"37","author":"Kaira","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00259-013-2477-9","article-title":"Diagnostic usefulness of 18F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma","volume":"40","author":"Nobusawa","year":"2013","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12149-019-01346-9","article-title":"Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2","volume":"33","author":"Aoki","year":"2019","journal-title":"Ann. Nucl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2967\/jnumed.109.066837","article-title":"18F-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non\u2013Small Cell Lung Cancer","volume":"50","author":"Kaira","year":"2009","journal-title":"J. Nucl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/ijc.24034","article-title":"Evaluation of thoracic tumors with (18)F-FMT and (18)F-FDG PET-CT: A clinicopathological study","volume":"124","author":"Kaira","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19745","DOI":"10.1074\/jbc.274.28.19745","article-title":"Identification and Functional Characterization of a Na+-independent Neutral Amino Acid Transporter with Broad Substrate Selectivity","volume":"274","author":"Segawa","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_37","first-page":"663","article-title":"Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: A potential tumor-detecting agent","volume":"39","author":"Inoue","year":"1998","journal-title":"J. Nucl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12149-010-0398-2","article-title":"18F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: Comparative study with 18F-FDG PET and immunohistochemistry","volume":"24","author":"Miyashita","year":"2010","journal-title":"Ann. Nucl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/bjc.2014.142","article-title":"Biological significance of fluorine-18-\u03b1-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer","volume":"110","author":"Suzuki","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_40","first-page":"399","article-title":"18F alpha-methyl tyrosine PET studies in patients with brain tumors","volume":"40","author":"Inoue","year":"1999","journal-title":"J. Nucl. Med."},{"key":"ref_41","first-page":"1680","article-title":"Simultaneous emission and transmission measurements for attenuation correction in whole-body PET","volume":"36","author":"Meikle","year":"1995","journal-title":"J. Nucl. Med."},{"key":"ref_42","first-page":"1424","article-title":"In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer","volume":"39","author":"Amano","year":"1998","journal-title":"J. Nucl. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jphs.2016.01.001","article-title":"Transport of 3-fluoro-l-\u03b1-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [18F]FAMT positron emission tomography","volume":"130","author":"Wei","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.120.000235","article-title":"Interaction of Halogenated Tyrosine\/Phenylalanine Derivatives with Organic Anion Transporter 1 in the Renal Handling of Tumor Imaging Probes","volume":"375","author":"Jin","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.1158\/1078-0432.CCR-07-1294","article-title":"Fluorine-18-\u03b1-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer: A Clinicopathologic Study","volume":"13","author":"Kaira","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1349-7006.2008.01077.x","article-title":"Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer","volume":"100","author":"Kaira","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1245\/s10434-010-1177-y","article-title":"18F-FAMT-PET Is Useful for the Diagnosis of Lymph Node Metastasis in Operable Esophageal Squamous Cell Carcinoma","volume":"17","author":"Sohda","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12149-013-0701-0","article-title":"Clinical significance of 18F-\u03b1-methyl tyrosine PET\/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: Comparison with 18F-FDG PET\/CT and MRI","volume":"27","author":"Kim","year":"2013","journal-title":"Ann. Nucl. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13550-017-0298-8","article-title":"Clinical value of fluorine-18\u03b1-methyltyrosine PET in patients with gliomas: Comparison with fluorine-18 fluorodeoxyglucose PET","volume":"7","author":"Horiguchi","year":"2017","journal-title":"EJNMMI Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/s00259-013-2487-7","article-title":"Complementary roles of tumour specific PET tracer 18F-FAMT to 18F-FDG PET\/CT for the assessment of bone metastasis","volume":"40","author":"Morita","year":"2013","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s12149-012-0645-9","article-title":"18F-FAMT in patients with multiple myeloma: Clinical utility compared to 18F-FDG","volume":"26","author":"Isoda","year":"2012","journal-title":"Ann. Nucl. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2967\/jnumed.114.144014","article-title":"Effects of Intratumoral Inflammatory Process on 18F-FDG Uptake: Pathologic and Comparative Study with 18F-Fluoro-\u03b1-Methyltyrosine PET\/CT in Oral Squamous Cell Carcinoma","volume":"56","author":"Kim","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Kumasaka, S., Nakajima, T., Arisaka, Y., Tokue, A., Achmad, A., Fukushima, Y., Shimizu, K., Kaira, K., Higuchi, T., and Tsushima, Y. (2018). Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET\/CT in non-small cell lung Cancer. BMC Med. Imaging, 18.","DOI":"10.1186\/s12880-018-0292-2"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.21873\/anticanres.11247","article-title":"Usefulness of 18F-\u03b1-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer","volume":"36","author":"Kaira","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2214\/AJR.09.4167","article-title":"Assessment of therapy response in lung cancer with 18F-\u03b1-methyl tyrosine PET","volume":"195","author":"Kaira","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_56","first-page":"909","article-title":"L-[3-18F]-\u03b1-methyltyrosine accumulation as a definitive chemoradiotherapy response predictor in patients with esophageal cancer","volume":"34","author":"Sohda","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_57","first-page":"3623","article-title":"Use of pre-treatment 18F-FAMT PET to predict patient survival in squamous cell carcinoma of the esophagus treated by curative surgery","volume":"34","author":"Sohda","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11282-019-00377-2","article-title":"18F-FDG and 18F-FAMT PET-derived metabolic parameters predict outcome of oral squamous cell carcinoma","volume":"35","author":"Kim","year":"2019","journal-title":"Oral Radiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"596","DOI":"10.6004\/jnccn.2011.0053","article-title":"Head and neck cancers","volume":"9","author":"Pfister","year":"2011","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/lary.23409","article-title":"Comparison of whole body positron emission tomography (PET)\/PET-computed tomography and conventional anatomic imaging for detecting distant malignancies in patients with head and neck cancer: A meta-analysis","volume":"122","author":"Xu","year":"2012","journal-title":"Laryngoscope"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00234-003-1057-2","article-title":"Gliomatosis cerebri evaluated by 18F?-methyl tyrosine positron-emission tomography","volume":"45","author":"Sato","year":"2003","journal-title":"Neuroradiology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12880-015-0104-x","article-title":"Differentiation of sarcoidosis-lymphoma syndrome lesions: A case report on the use of two different positron emission tomography tracers","volume":"16","author":"Yudistiro","year":"2016","journal-title":"BMC Med. Imaging"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.nucmedbio.2011.02.001","article-title":"Prepara-tion and biological evaluation of 3-[(76)Br]bromo-alpha-methyl-L-tyrosine, a novel tyrosine analog for positron emission to-mography imaging of tumors","volume":"38","author":"Ohshima","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.7150\/thno.99490","article-title":"LAT1-specific PET radiotracers: Development and clinical experiences of a new class of cancer-specific radiopharmaceuticals","volume":"15","author":"Achmad","year":"2025","journal-title":"Theranostics"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/cas.14761","article-title":"alpha-Emitting cancer therapy using (211) At-AAMT targeting LAT1","volume":"112","author":"Zhang","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.18632\/oncotarget.27552","article-title":"Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice","volume":"11","author":"Watabe","year":"2020","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2967\/jnumed.114.152215","article-title":"Development of a Widely Usable Amino Acid Tracer: (7)(6)Br-alpha-Methyl-Phenylalanine for Tumor PET Im-aging","volume":"56","author":"Hanaoka","year":"2015","journal-title":"J. Nucl. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5848\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:54:21Z","timestamp":1760032461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":67,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ijms26125848"],"URL":"https:\/\/doi.org\/10.3390\/ijms26125848","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]}}}